Cdc42 functions as a regulatory node for tumour-derived microvesicle biogenesis.

Area of Science:

• Cancer Biology
• Cellular Biology
• Molecular Oncology

Background:

• Tumour-derived microvesicles (MVs) are key mediators of intercellular communication within the tumour microenvironment.
• Mechanisms regulating MV biogenesis and release, particularly how oncogenic signaling pathways like EGF signaling influence this process, remain poorly understood.

Purpose of the Study:

• To establish reliable methods for measuring MV biogenesis.
• To investigate the molecular mechanisms governing MV generation and release.
• To explore the role of abnormal EGF signaling in MV release.

Main Methods:

• Investigated the role of Rho family small G protein Cdc42 in MV biogenesis.
• Analyzed the interaction between Cdc42 and its effector IQGAP1 in MV shedding.
• Utilized mutant signaling pathways to assess their impact on MV release and tumour angiogenesis.

Main Results:

• Cdc42 acts as a central regulator in MV biogenesis.
• The binding of activated Cdc42 to IQGAP1 is essential for MV shedding.
• Activated Cdc42 sustains EGF signaling by preventing receptor internalization, thereby promoting MV release.
• Inhibition of these pathways reduced MV shedding and tumour angiogenesis in vivo.

Conclusions:

• Tumour cells exhibit complex regulation of MV shedding.
• This study elucidates a key regulatory mechanism of MV biogenesis.
• Findings provide potential therapeutic strategies targeting MVs in cancer treatment.